Topiramate Capsule, Extended Release
Product Images NDC 10370-368

4 FDA label images from Par Health Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 10370-368). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical_structure.jpg (Topiramate 1)

Chemical_structure.jpg (Topiramate 1)
Chemical structure of Topiramate, depicting its molecular framework with oxygen, sulfur, nitrogen, carbon, and hydrogen atoms arranged in a complex ring and side groups.*
FDA Label Image

Topiramate Er Capsule (Topiramate 2)

Topiramate Er Capsule (Topiramate 2)
A Kaplan-Meier curve chart showing cumulative rates of time to first seizure over 500 days for Topiramate at 50 mg/day and 400 mg/day dosages. The chart compares two groups with sample sizes of 234 and 236, respectively, indicating differences in seizure occurrence over time with statistical significance (p = 0.0002).*
FDA Label Image

Topiramate Er Capsule (Topiramate 3)

Topiramate Er Capsule (Topiramate 3)
A bar graph showing changes from baseline to double-blind phase in average monthly migraine period rate for Topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day, compared to Placebo. It displays two studies with error bars, illustrating reductions in migraine rates with increasing Topiramate doses.*
FDA Label Image

200_mg_-_30s_-_par_health.jpg (Topiramate 4)

200_mg_-_30s_-_par_health.jpg (Topiramate 4)
Label for Topiramate Extended-Release Capsules 200 mg by Par Health USA, LLC. The label indicates a 30-capsule count, oral extended-release capsules with yellow opaque cap and white opaque body. It includes instructions for swallowing the capsule whole and storage recommendations at controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.